肠胃清胶囊治疗慢性胃炎60例

目的：观察自制中药肠胃清胶囊治疗慢性胃炎的临床效果。方法：根据《中药新药临床研究指导原则》的标准，采用自身前后对比的方法，对临床症状、体征及相关检查从中医两个方面进行治疗前后对比。结果：肠胃清胶囊对慢性胃炎的症状、体征有明显疗效，对胃黏膜镜下病变及组织学变化亦有明显的改善作用。结论：肠胃清胶囊对偏热偏实型慢性胃炎具有明显疗效。临床观察中未发现毒性和不良反应。     

百鹰汤治疗慢性乙型肝炎43例

目的：观察以“温阳益气、化湿清热”为法拟方的百鹰汤治疗慢性乙型肝炎的临床疗效。方法：43例慢性乙型肝炎采用百鹰汤治疗作为治疗组，另设30例随机对照组以五酯胶囊治疗。结果：治疗组患临床症状改善明显，其降酶疗效和HBeAg与HBV－DNA阴转率明显优于对照组（P＜0．05）。结论：百鹰汤能改善慢性乙型肝炎患临床症状，具有抗病毒及改善肝功能的作用。     

中药口服与灌肠配合氦-氖激光治疗老年人慢性肾功能衰竭临床观察

观察调中益肾活血通腑中药口服与灌肠配合低能量氦 -氖激光血管内照射(ILIB)疗法对老年人慢性肾功能衰竭 (CRF)的疗效。治疗组予中药口服与灌肠配合ILIB疗法 ,并与阳性对照药依那普利作比较。结果 :两组病例在Scr、BUN、尿蛋白方面均有显著降低 ,但治疗组在改善临床症状、提高红细胞SOD及血浆免疫球蛋白方面均优于对照组。结论 :调中益肾活血通腑中药口服与灌肠配合ILIB疗法具有明显改善老年CRF的肾功能、调整胃肠机能、提高机体免疫能力的作用。     

Outpatient laparoscopic cholecystectomy: a reality.

BACKGROUND: The author reports on his personal experience with outpatient laparoscopic cholecystectomy (LC), focusing on the main guidelines for preoperative and postoperative care and operating technique. METHODS: From January 1, 2000 to December 31, 2000, 71 laparoscopic cholecystectomies were performed on outpatients. The patients remained in the outpatient surgery center for 36 hours. In 4 cases, the operation was converted into laparotomy. Twenty patients remained in the hospital and were discharged 5 to 7 days later. Twelve were rehospitalized due to pathologies that could not be treated at home. RESULTS: In all 71 cases, a complete remission of the symptoms occurred, and none of the patients died either during the operation or during the postoperative period. Eighty percent of patients were treated in outpatient surgery centers. CONCLUSIONS: With clear guidelines, LC is a major surgical operation that can be performed in outpatient surgery centers without death or other major complications and with very good remission of symptoms.     

老年慢性病患者常见症状与生存质量的相关性研究

目的 探讨老年慢性病患者常见症状间的相互关系及其对生存质量的影响,以寻找提高其生存质量的护理对策.方法 采用焦虑自评量表、老年人抑郁量表、SF-36量表对230例老年慢性病患者进行常见症状及生存质量调查,并分析各种症状间的关系以及症状与生存质量的相关性.结果 老年慢性病患者生存质量八大项目得分偏低.常见躯体症状包括躯体疼痛、头晕、疲乏、睡眠障碍发生率依次为25.73%、33.80%、25.00%、22.05%.常见心理症状焦虑和抑郁得分为38.35±7.26、8.71±5.21.且各种常见症状之间呈正相关(r=0.80～0.612,P<0.05),各种常见症状与生存质量呈负相关(r=-0.175～-0.623,P<0.05).结论 在老年慢性病患者居家护理过程中,须及时采取积极有效护理措施控制或减轻病人症状,且躯体症状护理与心理护理应并重,措施实施与原因排查应同步,主要症状与次要症状要兼顾,以提高其生存质量.     

肺心病患者血清碱性成纤维细胞生长因子水平的变化及其与肺动脉压的关系

目的　探讨碱性成纤维细胞生长因子 (b FGF)在低氧性肺动脉高压发病中的作用。方法　采用酶联免疫吸附法对具有低氧性肺动脉高压的肺心病患者 2 1例、无低氧性肺动脉高压的慢性阻塞性肺疾病 (COPD)患者 2 3例和 2 4例正常人血清 b FGF水平进行检测 ,以多普勒超声心动仪测定肺心病和 COPD患者的平均肺动脉压 (m PAP)。结果　肺心病组 m PAP水平 (33.33± 7.0 3m m Hg)明显高于 COPD组 (13.13± 2 .34mm Hg) ,P<0 .0 0 1;肺心病组血清 b FGF水平 (6 9.84± 16 .2 9pg/m l)明显高于 COPD组 (43.94± 7.5 7pg/ml)和正常对照组(44 .6 4± 6 .31pg/m l) ,P<0 .0 0 1;肺心病血清 b FGF水平与 m PAP之间呈明显正相关 ,r=0 .730 ,P<0 .0 0 1。结论慢性肺心病患者血清 b FGF水平明显升高 ,可能与其慢性低氧性肺动脉高压的形成有一定的关系。     

Discrimination of idiopathic pain syndromes from neurogenic pain syndromes and healthy volunteers by means of clinical rating,personality traits,monoamine metabolites in CSF,serum cortisol,platelet MAO and urinary melatonin

Summary The aim of the present study was to investigate the discriminative power of a series of variables (including determination of depressive symptomatology by means of a visual analogue scale, determination of personality traits by means of the Karolinska Scales of Personality, determination of monoamine metabolites in CSF, platelet MAO activities, serum cortisol before and after dexamethasone suppression and urinary melatonin) in differentiating (a) chronic pain patients from healthy subjects, and (b) patients with idiopathic pain syndromes from patients with neurogenic pain syndromes. Separately each of the measures gave a significant but often low contribution to the discrimination, while a combination of several measures gave a complete discrimination both between healthy subjects and patients with chronic pain syndromes and between patients with idiopathic and neurogenic pain syndromes, respectively.Supported in part by grants from the Swedish Medical Research Council (grants no. 3371, 4145 and 5740) and by a grant from Stiftelsen Söderström-Königska Sjukhemmet     

Chronic lymphocytic leukaemia and lymphoma in an Iranian fat-tailed sheep: a case report

A 5-year-old Iranian fat-tailed sheep was referred to the Veterinary Clinic of Shiraz University in September 2003 with a history of emaciation, fever, decreased appetite, lethargy and cough. Small cutaneous and subcutaneous nodules were palpable, especially under the ribs on both sides of the thorax. Discrete cutaneous plaques and large scabby lesions were also observed. Very large mammary gland lymph nodes were noticed on palpation. Haematological and serum biochemical values were estimated through standard haematological and biochemical techniques. In this case a normocytic–normochromic anaemia, leukocytosis and lymphocytosis were found. The concentrations of blood urea nitrogen (BUN), creatinine, cholesterol and the activities of aspartate aminotransferase (AST) and gamma-glutamyl transferase (GGT) were higher than the values reported for sheep. Necropsy findings revealed that the lymph nodes were affected in most organs. Malignant lymphoma in the kidney, heart, spleen, mammary glands, liver and bone marrow was observed. The histopathological appearance of the affected tissues varied considerably, depending upon the degree of tumour infiltration. According to the history, clinical signs, laboratory findings, necropsy findings and histopathological examination the case was diagnosed as chronic lymphocytic leukaemia and lymphoma.     

复方丹参注射液干扰素治疗乙肝后肝纤维化

目的探讨复方丹参注射液联合干扰素治疗慢性乙肝患者的疗效。方法110例慢性乙肝患者，按随机方法分成①对照组30例，应用普通保肝药物治疗，疗程6个月；②丹参组30例，应用复方丹参注射液（每ml含丹参、降香各1g）30ml加入10％葡萄糖溶液300ml中静脉注射1个月；③IFN组30例，应用IFN—α 3MU，隔日一次肌内注射，3个月；④联合组20例，应用复方丹参注射液30ml加10％葡萄糖溶液300ml静脉注射1个月，IFN-α 3MU，隔日一次肌内注射，3个月。丹参组，IFN组和联合组保肝药物治疗同对照组。四组病例在性别、年龄、病程，治疗前肝功能等方面均无统计学差异。治疗前检测肝功能，肝炎病毒标志，血清HA、IV—C、PCI—Ⅱ，部分病例进行肝穿病理检查。治疗开始后每月检测肝功能，3个月（治疗后）和6个月（随访时）时检测血清HA、IV—C、PCⅢ及乙肝病毒标志，治疗后1年行肝穿病理检查。结果治疗前四组患者血清HA、PCⅢ、IV—C水平无统计学差异；治疗后丹参组、IFN组、联合组血清HA、FCⅢ、IV—C水平较治疗前及对照组有不同程度的降低。结论复方丹参注射液联合IFN治疗可使血清HA、PCⅢ、IV—C有明显下降，肝组织病理改变明显改善，为目前有效的慢性乙肝治疗措施。     

Ill-health as a household norm: Evidence from other people's health problems

This paper proposes that an individual's self-assessed health (SAH) does not only suffer from systematic reporting bias and adaptation bias but is also biased owing to confounding health norm effects. Using 13 waves of the British Household Panel Survey covering the period 1991–2005, I show that, while there is a negative and statistically significant correlation between SAH and individuals' own health problem index, this negative effect reduces with the average number of health problems per (other) family member. The relative health bias is small, however, which implies that measures of SAH may not suffer seriously from systematic health norm bias. This is an important finding for researchers working with SAH data as it indicates that we do not have to worry too much about controlling for confounding influences from the health of other household members when estimating SAH regression equations.